Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Marker Therapeutics, Inc. MRKR
$1.28
-$0.03 (-2.29%)
На 18:01, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
12325511.00000000
-
week52high
6.60
-
week52low
0.67
-
Revenue
9004530
-
P/E TTM
0
-
Beta
0.95847700
-
EPS
-4.13000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 12:30
Описание компании
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Roth Capital | Neutral | Buy | 17 февр 2022 г. |
Piper Sandler | Overweight | 25 мар 2021 г. | |
Cantor Fitzgerald | Overweight | 19 мар 2021 г. | |
Cantor Fitzgerald | Overweight | 18 мар 2021 г. | |
Piper Sandler | Neutral | Overweight | 12 мая 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
ELMS STEVE | A | 80000 | 80000 | 24 мая 2022 г. |
Wilson John Robert | A | 80000 | 80000 | 24 мая 2022 г. |
Eansor Norman David | A | 80000 | 80000 | 24 мая 2022 г. |
Knobil Katharine | A | 80000 | 80000 | 24 мая 2022 г. |
Laskow-Pooley David | A | 80000 | 80000 | 24 мая 2022 г. |
Hoang Peter L. | D | 483286 | 48376 | 24 мар 2022 г. |
Hoang Peter L. | A | 531662 | 199094 | 24 мар 2022 г. |
Kim Anthony H. | D | 114436 | 36076 | 24 мар 2022 г. |
Kim Anthony H. | A | 150512 | 150512 | 24 мар 2022 г. |
Vera Juan | D | 2671845 | 33465 | 24 мар 2022 г. |
Новостная лента
7 Low Float Penny Stocks To Watch After SNTG Stock Explodes
PennyStocks
01 мая 2023 г. в 12:10
More low float penny stocks to watch. The post 7 Low Float Penny Stocks To Watch After SNTG Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 18:48
MARKER THERAPEUTICS, INC. (MRKR) delivered earnings and revenue surprises of 38.46% and 393.75%, respectively, for the quarter ended September 2022.
3 Hot Penny Stocks To Buy For Under $1 Right Now
PennyStocks
14 окт 2022 г. в 12:53
If you're watching the action in the stock market today, you're seeing plenty of chop. The U.S. dollar's strength has pushed broader markets lower, but a mix of positive and negative economic against this week's PPI data and CPI data has brought much more push-pull action.